Biogen Pharma

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.30
0.00 (0.00%)
BSENSE

Aug 11

BSE+NSE Vol: 23.93 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.30",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.30",
    "mcapval": "31.59 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE703D01023",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "23.93 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4002822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_mojoScore_4002822.png",
        "date": "2026-05-21 10:10:22",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs036-4002444",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_4002444.png",
        "date": "2026-05-21 09:40:43",
        "description": ""
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.42 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs042-3989693",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3989693.png",
        "date": "2026-05-13 15:35:07",
        "description": "A sharp decline has pushed Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.42 on 13 May 2026, marking a significant 61% drop from its peak of Rs 1.08 within the last year. This downturn comes despite some improvement in profitability, highlighting a complex interplay of valuation and market sentiment pressures."
      }
    ],
    "total": 15,
    "sid": "200854",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.",
      "datetime": "05-Aug-2026",
      "details": "Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Wednesday 5th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:15 PM and concluded at 03:35 PM Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015",
      "datetime": "05-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
      "datetime": "05-Aug-2026",
      "details": "PFA",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26",
          "dt": "2026-05-15",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th August 2026.

05-Aug-2026 | Source : BSE

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company in their meeting held on today i.e. Wednesday 5th August2026. at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June 2026. The board meeting commented at 03:15 PM and concluded at 03:35 PM Please take the above intimation in your records. Thanking You.

Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015

05-Aug-2026 | Source : BSE

PFA

Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)

05-Aug-2026 | Source : BSE

PFA

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Biogen Pharmachem Industries Ltd has announced 1:6 bonus issue, ex-date: 15 May 26

stock-summary
RIGHTS

No Rights history available